Ellenőrzések Sample Clauses

Ellenőrzések. 00.0.Xx Ügyfél jogosult az Ügyfél Személyes Adatai tekintetében a szolgáltatások nyújtását xx x xxxxx Megállapodás rendelkezéseinek betartását – így, többek között, az adatkezelés biztonságának biztosítása érdekében tett technikai és szervezési intézkedéseket – ellenőrizni.
AutoNDA by SimpleDocs

Related to Ellenőrzések

  • Millwright In the case of a job site located outside a millwright’s region of residence, the employer may assign a millwright holding a journeyman competency certificate or an apprentice competency certificate anywhere in Quebec, provided the millwright has worked 1,500 or more hours for the employer in the construction industry in Quebec or elsewhere in Canada during the first 24 months of the 26 months preceding the issuance or renewal of his competency certificate, as follows:

  • Vynálezy Stávající vynálezy a technologie Zadavatele nebo Zdravotnického zařízení zakládají jejich samostatné vlastnictví a Smlouva na ně nemá žádný vliv. Kompletní práva, nároky a podíly ohledně veškerých vynálezů, know-how, autorských práv nebo jiných práv duševního vlastnictví, které vzniknou, budou vyvinuty nebo použity v praxi (včetně veškerých zlepšení nebo úprav), které i) používají, využívají nebo zahrnují Hodnocené léky; ii) jsou zahrnuty nebo předvídány v Protokolu; nebo iii) používají, využívají nebo zahrnují Důvěrné informace, zakládají výlučné vlastnictví Zadavatele (společně xxxx xxx „Vynálezy Zadavatele“). Zdravotnické zařízení je povinno bezodkladně písemně informovat PRA a/nebo Zadavatele o každém takovém Vynálezu Zadavatele, a tímto převádí (a zajistí, aby všichni členové studijního týmu převedli) na Zadavatele veškerá práva, nároky a podíly týkající se každého jednotlivého Vynálezu Zadavatele. Zdravotnické zařízení se zavazuje poskytnout Zadavateli na jeho náklady přiměřenou pomoc, xxx xxxx Zadavatel smluvně zajistit a vykonávat svá práva na takové Vynálezy Zadavatele. Zdravotnické zařízení má výlučný vlastnický titul ke všem vynálezům nebo objevům, které vzniknou nebo budou použity v praxi výhradně zásluhou Zdravotnického zařízení, a které nenáleží Zadavateli. 9.

  • Sergeant Twenty percent (20%) over the top step hourly rate for Sergeant when acting as a supervisor (otherwise twenty percent (20%) over the top step hourly rate for Police Officer).

  • moorditj kwabadak Healthy people refers to the commitment we have as an organisation to ensure our staff, patients and the wider community have access to comprehensive healthcare services, in order to maintain healthy lives. Amazing care reflects the sentiment of those consumers accessing our healthcare services from feedback provided to us. This common statement resonates with the health service, and reflects our intentions in our practice and work every day. As a health service which celebrates diversity of culture and languages, it is also important that our vision is shared in the Noongar language. Our Values Our Values reflect the qualities that we demonstrate to each other and our community every day. Our staff make a difference every day to the patients, families and consumers they provide care, advice and support to. The EMHS values capture the shared responsibility that we uphold as most important, which are: • Kindness – kindness is represented in the support that we give to one another. This is how we demonstrate genuine care and compassion to each and every person.

  • meminta nasihat daripada Pihak Xxxxxx dalam semua perkara berkenaan dengan jualan lelongan, termasuk Syarat-syarat Jualan (iii) membuat carian Hakmilik Xxxxx xxxxxx rasmi di Pejabat Tanah xxx/atau xxxx- xxxx Pihak-pihak Berkuasa yang berkenaan xxx (iv) membuat pertanyaan dengan Pihak Berkuasa yang berkenaan samada jualan ini terbuka kepada semua bangsa atau kaum Bumiputra Warganegara Malaysia sahaja atau melayu sahaja xxx juga mengenai persetujuan untuk jualan ini sebelum jualan lelong.Penawar yang berjaya ("Pembeli") dikehendaki dengan segera memohon xxx mendapatkan kebenaran pindahmilik (jika ada) daripada Pihak Pemaju xxx/atau Pihak Tuanpunya xxx/atau Pihak Berkuasa Negeri atau badan-badan berkenaan (v) memeriksa xxx memastikan samada jualan ini dikenakan cukai. BUTIR-BUTIR HARTANAH : HAKMILIK : Hakmilik strata bagi hartanah ini telah dikeluarkan oleh pihak berkuasa. HAKMILIK STRATA / LOT NO : Geran 336320/L239, Lot No.45677 BANDAR /DISTRICT/STATE : Beranang / Hulu Langat / Selangor Darul Ehsan. PEGANGAN : Selama-lamanya KELUASAN LANTAI : 130 meter persegi (1,399 kaki persegi) SYARAT-SYARAT NYATA : “Bangunan Kediaman” TUANPUNYA BERDAFTAR : Eco Majestic Development Sdn Bhd (1079086-W) PENYERAH HAK : Xxxxxxxxxxxx a/x Xxxxxxx & Xxxxxxxxx a/p Xxxx Xxxxx BEBANAN : Diserahhak kepada RHB Bank Berhad [196501000373 (6171-M)] LOKASI XXX PERIHAL HARTANAH Hartanah tersebut terletak di Xxxxx Xxx Xxxxxx 0/0X, Xxx Xxxxxx, Xxxxxxxx, Xxxxxxxx Xxxxx Xxxxx. Hartanah tersebut adalah sebuah rumah teres dua tingkat berstrata unit pertengahan dikenali sebagai Xxxxx No.F1227, Eco Forest – Precinct 1 (Ebonylane) (Fasa 1B2) Rumah Teres Dua Tingkat xxx mempunyai alamat surat-menyurat di Xxxxxxxx Xx.00, Xxxxx Xxx Xxxxxx 0/0X, Xxx Xxxxxx, 00000 Xxxxxxxx, Xxxxxxxx Xxxxx Xxxxx. HARGA RIZAB: Harta ini dijual “keadaan seperti mana sediada” dengan harga rizab sebanyak RM 600,000.00 (RINGGIT MALAYSIA: ENAM RATUS RIBU SAHAJA) xxx tertakluk kepada syarat-syarat Jualan xxx melalui penyerahan hakkan dari Pemegang Serahak, tertakluk kepada kelulusan di perolehi oleh pihak Pembeli daripada pihak berkuasa, jika ada, termasuk semua terma, syarat xxx perjanjian yang dikenakan xxx mungkin dikenakan oleh Pihak Berkuasa yang berkenaan. Pembeli bertanggungjawab sepenuhnya untuk memperolehi xxx mematuhi syarat-syarat berkenaan daripada Pihak Berkuasa yang berkenaan, jika ada xxx semua xxx xxx perbelanjaan ditanggung xxx dibayar oleh Xxxxx Xxxxxxx.Pembeli atas talian (online) juga tertakluk kepada terma-terma xxx syarat-syarat terkandung dalam xxx.xxxxxxxxxxxxxxxx.xxx Pembeli yang berminat adalah dikehendaki mendeposit kepada Pelelong 10% daripada harga rizab dalam bentuk Bank Draf atau Cashier’s Order di atas nama RHB Bank Berhad sebelum lelongan awam xxx xxxx xxxx xxxxxx hendaklah dibayar dalam tempoh sembilan puluh (90) hari dari tarikh lelongan kepada RHB Bank Berhad melalui XXXXXX. Butir-butir pembayaran melalui XXXXXX, xxxx berhubung dengan Tetuan Che Mokhtar & Ling. Untuk maklumat lanjut, xxxx berhubung dengan TETUAN CHE MOKHTAR & LING, yang beralamat di Level 21, Main Block, Menara Takaful Malaysia, Xx.0, Xxxxx Xxxxxx Xxxxxxxx, 00000 Xxxxx Xxxxxx. Tel: 00-0000 0000 / Fax: 00-0000 0000 [ Ruj: CML-08A/RHB1/BM/45274/23 ] peguamcara bagi pihak pemegang xxxxx xxx atau pelelong yang tersebut dibawah. RAJAN AUCTIONEERS SDN. BHD. X. XXXXX Xx.00X, Xxxxxxx Xxxx,Xxxxx Xxxx Xxxxxx, ( Xxxxxxxx Berlesen ) 41000 Klang, Selangor Darul Ehsan. H/P: 000-0000000 Tel: 00-00000000 / Fax: 00-00000000 H/P: 012-2738109 Ruj Kami: RA/RHB/CML/KL/4204-24 (sri) CONDITIONS OF SALE

  • Sincerely, s/ Xxxx Xxxxx ---------------------------------------- Xxxx Xxxxx Senior Vice President ING Investors Trust ING Mutual Funds ING Variable Insurance Trust ACCEPTED AND AGREED TO: The Bank of New York By: /s/ Xxxxxx X. XxXxxx --------------------------------- Name: Xxxxxx X. XxXxxx Title: Managing Director, Duly Authorized 0000 X. Xxxxxxxxxx Xxxxx Xx. Tel: 000-000-0000 ING Investors Trust Scottsdale, AZ 00000-0000 Fax: 000-000-0000 ING Mutual Funds xxx.xxxxxxxx.xxx ING Variable Insurance Trust AMENDED EXHIBIT A FUND EFFECTIVE DATE ---- ------------------ ING CORPORATE LEADERS TRUST FUND ING Corporate Leaders Trust - Series A May 17, 2004 ING Corporate Leaders Trust - Series B May 17, 2004 ING EQUITY TRUST ING Convertible Fund June 9, 2003 ING Disciplined LargeCap Fund June 9, 2003 ING Financial Services Fund June 9, 2003 ING Fundamental Research Fund December 28, 2005 ING LargeCap Growth Fund June 9, 2003 ING LargeCap Value Fund February 1, 2004 ING MidCap Opportunities Fund June 9, 2003 ING MidCap Value Choice Fund February 1, 2005 ING MidCap Value Fund June 9, 2003 ING Opportunistic LargeCap Fund December 28, 2005 ING Principal Protection Fund June 2, 2003 ING Principal Protection Fund II June 2, 2003 ING Principal Protection Fund III June 2, 2003 ING Principal Protection Fund IV June 2, 2003 ING Principal Protection Fund V June 2, 2003 ING Principal Protection Fund VI June 2, 2003 ING Principal Protection Fund VII May 1, 2003 ING Principal Protection Fund VIII October 1, 2003 ING Principal Protection Fund IX February 2, 2004 ING Principal Protection Fund X May 3, 2004 ING Principal Protection Fund XI August 16, 2004 ING Principal Protection Fund XII November 15, 2004 ING Principal Protection Fund XIII TBD ING Principal Protection Fund XIV TBD ING Real Estate Fund June 9, 2003 ING SmallCap Opportunities Fund June 9, 2003 ING SmallCap Value Choice Fund February 1, 2005 ING SmallCap Value Fund June 9, 2003 ING FUNDS TRUST ING Classic Money Market Fund April 7, 2003 ING GNMA Income Fund April 7, 2003 ING High Yield Bond Fund April 7, 2003 ING Institutional Prime Money Market Fund July 29, 2005 ING Intermediate Bond Fund April 7, 2003 ING National Tax-Exempt Bond Fund April 7, 2003 ING GET FUND ING GET Fund - Series N July 14, 2003 ING GET Fund - Series P July 14, 2003 ING GET Fund - Series Q July 14, 2003 ING GET Fund - Series R July 14, 2003 ING GET Fund - Series S July 14, 2003 ING GET Fund - Series T July 14, 2003 ING GET Fund - Series U July 14, 2003 ING GET Fund - Series V March 13, 2003 ING GLOBAL EQUITY DIVIDEND AND PREMIUM OPPORTUNITY FUND March 28, 2005 ING GLOBAL ADVANTAGE AND PREMIUM OPPORTUNITY FUND October 27, 2005 ING INVESTMENT FUNDS, INC. ING MagnaCap Fund June 9, 2003 ING INVESTORS TRUST ING AllianceBernstein Mid Cap Growth Portfolio January 6, 2003 ING American Funds Growth Portfolio September 2, 2003 ING American Funds Growth-Income Portfolio September 2, 2003 ING American Funds International Portfolio September 2, 2003 ING Capital Guardian Small/Mid Cap Portfolio January 13, 2003 ING Capital Guardian U.S. Equities Portfolio January 13, 2003 ING Disciplined Small Cap Value Portfolio April 28, 2006 ING Eagle Asset Capital Appreciation Portfolio January 6, 2003 ING EquitiesPlus Portfolio April 28, 2006 ING Evergreen Health Sciences Portfolio May 3, 2004 ING Evergreen Omega Portfolio May 3, 2004 ING FMR(SM) Diversified Mid Cap Portfolio January 6, 2003 ING FMR(SM) Earnings Growth Portfolio April 29, 2005 ING FMR(SM) Equity Income Portfolio July 17, 2006 ING Franklin Income Portfolio April 28, 2006 ING Global Real Estate Portfolio January 3, 2006 ING Global Resources Portfolio January 13, 2003 ING Xxxxxxx Xxxxx Tollkeeper(SM) Portfolio January 6, 2003 ING International Portfolio January 13, 2003 ING Janus Contrarian Portfolio January 13, 2003 ING JPMorgan Emerging Markets Equity Portfolio January 13, 2003 ING JPMorgan Small Cap Equity Portfolio January 13, 2003 ING JPMorgan Value Opportunities Portfolio April 29, 2005 ING Xxxxxx Xxxx Foreign Portfolio January 13, 2003 ING Xxxx Xxxxx Partners All Cap Portfolio January 6, 2003 ING Xxxx Xxxxx Value Portfolio January 13, 2003 ING LifeStyle Aggressive Growth Portfolio May 1, 2004 ING LifeStyle Growth Portfolio May 1, 2004 ING LifeStyle Moderate Growth Portfolio May 1, 2004 ING LifeStyle Moderate Portfolio May 1, 2004 ING Limited Maturity Bond Portfolio January 6, 2003 ING Liquid Assets Portfolio January 6, 2003 ING Lord Xxxxxx Affiliated Portfolio January 6, 2003 ING MarketPro Portfolio August 1, 2005 ING MarketStyle Growth Portfolio August 1, 2005 ING MarketStyle Moderate Growth Portfolio August 1, 2005 ING MarketStyle Moderate Portfolio August 1, 2005 ING Xxxxxxx Growth Portfolio January 13, 2003 ING Xxxxxxx International Opportunities Portfolio April 29, 2005 ING Mercury Large Cap Growth Portfolio January 6, 2003 ING Mercury Large Cap Value Portfolio January 6, 2003 ING MFS Mid Cap Growth Portfolio January 13, 2003 ING MFS Total Return Portfolio January 13, 2003 ING MFS Utilities Portfolio April 29, 2005 ING Xxxxxxxxxxx Main Street Portfolio(R) January 13, 2003 ING PIMCO Core Bond Portfolio January 13, 2003 ING PIMCO High Yield Portfolio November 5, 2003 ING Pioneer Equity Income Portfolio July 17, 2006 ING Pioneer Fund Portfolio April 29, 2005 ING Pioneer Mid Cap Value Portfolio April 29, 2005 ING Stock Index Portfolio November 5, 2003 ING X. Xxxx Price Capital Appreciation Portfolio January 13, 2003 ING X. Xxxx Price Equity Income Portfolio January 13, 2003 ING Xxxxxxxxx Global Growth Portfolio January 13, 2003 ING UBS U.S. Allocation Portfolio January 6, 2003 ING Xxx Xxxxxx Equity Growth Portfolio January 13, 2003 ING Xxx Xxxxxx Global Franchise Portfolio January 13, 2003 ING Xxx Xxxxxx Growth and Income Portfolio January 13, 2003 ING Xxx Xxxxxx Real Estate Portfolio January 13, 2003 ING VP Index Plus International Equity Portfolio July 29, 2005 ING Xxxxx Fargo Mid Cap Disciplined Portfolio January 6, 2003 ING Xxxxx Fargo Small Cap Disciplined Portfolio November 30, 2005 ING MAYFLOWER TRUST ING International Value Fund November 3, 2003 ING MUTUAL FUNDS ING Diversified International Fund December 7, 2005 ING Emerging Countries Fund November 3, 2003 ING Emerging Markets Fixed Income Fund December 7, 2005 ING Foreign Fund July 1, 2003 ING Global Bond Fund June 19, 2006 ING Global Equity Dividend Fund September 2, 2003 ING Global Real Estate Fund November 3, 2003 ING Global Value Choice Fund November 3, 2003 ING Greater China Fund December 7, 2005 ING Index Plus International Equity Fund December 7, 2005 ING International Capital Appreciation Fund December 7, 2005 ING International Fund November 3, 2003 ING International Real Estate Fund February 28, 2006 ING International SmallCap Fund November 3, 2003 ING International Value Choice Fund February 1, 2005 ING Precious Metals Fund November 3, 2003 ING Russia Fund November 3, 2003 ING PARTNERS, INC. ING American Century Large Company Value Portfolio January 10, 2005 ING American Century Select Portfolio January 10, 2005 ING American Century Small-Mid Cap Value Portfolio January 10, 2005 ING Baron Asset Portfolio December 7, 2005 ING Baron Small Cap Growth Portfolio January 10, 2005 ING Columbia Small Cap Value II Portfolio April 28, 2006 ING Xxxxx Venture Value Portfolio January 10, 2005 ING Fidelity(R) VIP Contrafund(R) Portfolio November 15, 2004 ING Fidelity(R) VIP Equity-Income Portfolio November 15, 2004 ING Fidelity(R) VIP Growth Portfolio November 15, 2004 ING Fidelity(R) VIP Mid Cap Portfolio November 15, 2004 ING Fundamental Research Portfolio January 10, 2005 ING Xxxxxxx Xxxxx(R) Capital Growth Portfolio January 10, 2005 ING Xxxxxxx Xxxxx(R) Structured Equity Portfolio January 10, 2005 ING JPMorgan International Portfolio January 10, 2005 ING JPMorgan Mid Cap Value Portfolio January 10, 2005 ING Xxxx Xxxxx Partners Aggressive Growth Portfolio January 10, 2005 ING Xxxx Xxxxx Partners Large Cap Growth Portfolio January 10, 2005 ING Lord Xxxxxx U.S. Government Securities Portfolio December 7, 2005 ING MFS Capital Opportunities Portfolio January 10, 2005 ING Xxxxxxxxx Xxxxxx Partners Portfolio December 7, 2005 ING Xxxxxxxxx Xxxxxx Regency Portfolio December 7, 2005 ING OpCap Balanced Value Portfolio January 10, 2005 ING Xxxxxxxxxxx Global Portfolio January 10, 2005 ING Xxxxxxxxxxx Strategic Income Portfolio January 10, 2005 ING PIMCO Total Return Portfolio January 10, 2005 ING Pioneer High Yield Portfolio December 7, 2005 ING Solution 2015 Portfolio April 29, 2005 ING Solution 2025 Portfolio April 29, 2005 ING Solution 2035 Portfolio April 29, 2005 ING Solution 2045 Portfolio April 29, 2005 ING Solution Income Portfolio April 29, 2005 ING X. Xxxx Price Diversified Mid Cap Growth Portfolio January 10, 2005 ING X. Xxxx Price Growth Equity Portfolio January 10, 2005 ING Xxxxxxxxx Foreign Equity Portfolio November 30, 2005 ING UBS U.S. Large Cap Equity Portfolio January 10, 2005 ING UBS U.S. Small Cap Growth Portfolio April 28, 2006 ING Xxx Xxxxxx Xxxxxxxx Portfolio January 10, 2005 ING Xxx Xxxxxx Equity and Income Portfolio January 10, 2005 ING SERIES FUND, INC. Brokerage Cash Reserves June 2, 2003 ING 130/30 Fundamental Research Fund April 28, 2006 ING Aeltus Money Market Fund June 2, 2003 ING Balanced Fund June 2, 2003 ING Equity Income Fund June 9, 2003 ING Global Science and Technology Fund June 2, 2003 ING Growth Fund June 9, 2003 ING Index Plus LargeCap Fund June 9, 2003 ING Index Plus MidCap Fund June 9, 2003 ING Index Plus SmallCap Fund June 9, 2003 ING International Growth Fund November 3, 2003 ING Small Company Fund June 9, 2003 ING Strategic Allocation Conservative Fund June 2, 2003 ING Strategic Allocation Growth Fund June 2, 2003 ING Strategic Allocation Moderate Fund June 2, 2003 ING STRATEGIC ALLOCATION PORTFOLIOS, INC. ING VP Strategic Allocation Conservative Portfolio July 7, 2003 ING VP Strategic Allocation Growth Portfolio July 7, 2003 ING VP Strategic Allocation Moderate Portfolio July 7, 2003 ING VARIABLE FUNDS ING VP Growth and Income Portfolio July 7, 2003 ING VARIABLE INSURANCE TRUST ING GET U.S. Core Portfolio - Series 1 June 13, 2003 ING GET U.S. Core Portfolio - Series 2 September 12, 2003 ING GET U.S. Core Portfolio - Series 3 December 12, 2003 ING GET U.S. Core Portfolio - Series 4 March 12, 2004 ING GET U.S. Core Portfolio - Series 5 June 11, 2004 ING GET U.S. Core Portfolio - Series 6 September 10, 2004 ING GET U.S. Core Portfolio - Series 7 December 10, 2004 ING GET U.S. Core Portfolio - Series 8 March 9, 2005 ING GET U.S. Core Portfolio - Series 9 June 8, 2005 ING GET U.S. Core Portfolio - Series 10 September 7, 2005 ING GET U.S. Core Portfolio - Series 11 December 6, 2005 ING GET U.S. Core Portfolio - Series 12 March 2, 2006 ING GET U.S. Core Portfolio - Series 13 June 22, 2006 ING VP Global Equity Dividend Portfolio November 3, 2003 ING VARIABLE PORTFOLIOS, INC. ING VP Global Science and Technology Portfolio July 7, 2003 ING VP Growth Portfolio July 7, 2003 ING VP Index Plus LargeCap Portfolio July 7, 2003 ING VP Index Plus MidCap Portfolio July 7, 2003 ING VP Index Plus SmallCap Portfolio July 7, 2003 ING VP International Equity Portfolio November 3, 2003 ING VP Small Company Portfolio July 7, 2003 ING VP Value Opportunity Portfolio July 7, 2003 ING VARIABLE PRODUCTS TRUST ING VP Financial Services Portfolio May 1, 2004 ING VP High Yield Bond Portfolio October 6, 2003 ING VP International Value Portfolio November 3, 2003 ING VP LargeCap Growth Portfolio October 6, 2003 ING XX XxxXxx Opportunities Portfolio October 6, 2003 ING VP Real Estate Portfolio May 1, 2004 ING VP SmallCap Opportunities Portfolio October 6, 2003 ING VP BALANCED PORTFOLIO, INC. July 7, 2003 ING VP INTERMEDIATE BOND PORTFOLIO July 7, 2003 ING VP MONEY MARKET PORTFOLIO July 7, 2003 ING VP NATURAL RESOURCES TRUST October 6, 2003

  • Povinnosti Zkoušejícího Investigator is responsible for the conduct of the Study at Institution and for supervising any individual or party to whom the Investigator delegates Study-related duties and functions (including Study Staff). In particular, but without limitation, it is the Investigator’s duty to review and understand the information in the Investigator’s Brochure or device labeling instructions. IQVIA or Sponsor will ensure that all required reviews and approvals by applicable regulatory authorities and ECs are obtained. The Investigator is responsible prior to commencement of the study to ensure that all approvals by applicable regulatory authorities and ECs have been obtained and to review all CRFs to ensure their accuracy and completeness. The Investigator will ensure that the Study Staff is fully informed about the Investigational Product and the Study and warrants that the Study Staff has read and understood the Protocol. If the Investigator and Institution retain the services of any individual or party to perform Study-related duties and functions, the Institution and Investigator shall ensure this individual, or party is qualified to perform those Study-related duties and functions and shall implement procedures to ensure the integrity of the Study-related duties and functions performed and any data generated. Zkoušející je odpovědný za provedení Studie ve Zdravotnickém zařízení a za dohled nad všemi fyzickými či právnickými osobami, kterým svěří povinnosti a funkce (včetně Studijního týmu) v souvislosti se Studií. Konkrétně pak jde zejména ale nejen o povinnost Zkoušejícího zkontrolovat a porozumět informacím obsaženým v Souboru informací pro zkoušejícího či pokynech k přístroji. IQVIA nebo Zadavatel zajistí, že budou opatřena veškerá požadovaná kontrolní schválení od příslušných regulatorních úřadů a EK. Zkoušející se zavazuje, že před zahájením Studie ověří, že byly získány veškeré souhlasy a povolení příslušných regulatorních úřadů a EK a že byly zkontrolovány všechny CRF tak, aby byla zajištěna jejich přesnost a úplnost. Zkoušející zajistí, aby byl Studijní tým plně seznámen s Xxxxxxxxxx léčivem a se Studií, a zaručí, že si Studijní tým přečte Protokol a bude mu rozumět. Pokud Zkoušející a Zdravotnické zařízení využívají k plnění povinností a funkcí v souvislosti se Studií služby jakékoli fyzické nebo právnické osoby, musejí zajistit, aby tyto fyzické nebo právnické osoby byly k plnění příslušných povinností a funkcí souvisejících se Studií způsobilé, a zavést postupy zaručující integritu povinností a funkcí prováděných v souvislosti se Studií a veškerých generovaných údajů. Investigator agrees to provide a written declaration revealing Investigator’s possible economic or other interests, if any, in connection with the conduct of the Study or the Investigational Product. Zkoušející souhlasí, že poskytne písemné prohlášení vztahující se k potenciálním zájmům Zkoušejícího ekonomické či jiné povahy, či odhalí jiné zájmy, je-li jich, a to v souvislosti s prováděním této Studie či ve vztahu k Hodnocenému léčivu. Investigator agrees to provide a written declaration revealing Investigator’s disclosure obligations, if any, with the Institution in connection with the conduct of the Study and the Investigational Product. Zkoušející souhlasí, že poskytne písemné prohlášení, jež bude odhalovat závazky Zkoušejícího, jsou-li nějaké, a to vůči Zdravotnickému zařízení ve vztahu a v souvislosti s prováděním Studie a Hodnoceným léčivem. Site agrees to provide prompt advance notice to Sponsor and IQVIA if Investigator will be terminating its employment relationship in the Institution or is otherwise no longer able to perform the Study. The appointment of a new Investigator must have the prior approval of Sponsor and IQVIA. Místo provádění klinického hodnocení souhlasí, že zašle předem promptní oznámení Zadavateli a IQVIA v případě, že Zkoušející ukončí pracovní poměr ve Zdravotnickém zařízení či nebude-li Zkoušející z jakéhokoli jiného důvodu schopen provádět Studii. Ustanovení nového Zkoušejícího bude podléhat předchozímu schválení Zadavatele a IQVIA.

  • Managing Director 1. The Managing Director shall be appointed by the Board of Governors from among candidates having the nationality of an ESM Member, relevant international experience and a high level of competence in economic and financial matters. Whilst holding office, the Managing Director may not be a Governor or Director or an alternate of either.

  • Datenschutzrichtlinie Ihre Informationen werden jederzeit gemäß der Apple Datenschutzrichtlinie behandelt, die durch Verweis in diese Lizenz integriert wird und unter folgender Adresse verfügbar ist: xxxx://xxx.xxxxx.xxx/de/privacy/.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!